+1 650-843-5192 nripberger@cooley.com
Noel Ripberger-Scheick practices general corporate and securities law, with an emphasis on the representation of emerging companies, public companies and venture capital funds.
Download full bio
Rigel Pharmaceuticals: $72 Million Follow-On
Establishment Labs – $76 Million IPO
Rapt Therapeutics – $38 Million IPO
Emerging Companies
Venture Capital
University of Michigan Law SchoolJD, 2017
The Ohio State UniversityBA, Economics and Englishwith honors, cum laude, 2013
California
Clearlake-Backed Perforce Acquires Rogue Wave Software January 29, 2019
+1 650-843-5192 office nripberger@cooley.com
3175 Hanover StreetPalo Alto, CA 94304-1130